In a pioneer study on the detection of altered sialylated N-glycan expression in CRC samples, it was demonstrated that the activity of ST6GAL1 is higher in tumor tissues compared to normal counterparts [86]. Here, ST6GAL1 is linked to colorectal carcinoma.